| A Study of Robot-Assisted Bronchoscopy in Chinese Participants With Lung Lesions (NCT05426213) | Auris Health, Inc. | 2022-07-12 |
| Endobronchial Ultrasound Needle Aspiration With and Without Suction (NCT05110950) | Università Politecnica delle Marche | 2022-06-01 |
| Evaluation of the Utility of Rapid On-site Cytology Performed by an Interventional Pulmonologist During EBUS-TBNA. (NCT07590947) | Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria | 2022-05-22 |
| Chest dRain rEmoval intrAoperatively afTer thoracOscopic Wedge Resection (NCT05358158) | Rigshospitalet, Denmark | 2022-05-04 |
| Mediastinal Lymph Node Dissection Versus Spared Mediastinal Lymph Node Dissection in Stage I GGN NSCLC (NCT04631770) | Tianjin Medical University Cancer Institute and Hospital | 2022-05-01 |
| The Effect of Interventional Pulmonary Rehabilitation Exercise With Advanced Lung Cancer. (NCT05279521) | National Taiwan University Hospital | 2022-03-20 |
| Envafolimab Combined With Endostar in the First-line Treatment of Advanced NSCLC (NCT05203276) | The First People's Hospital of Lianyungang | 2022-03-01 |
| Sitravatinib Plus Pembrolizumab in Patients With Advanced Treatment-Naïve PD-L1+ Non-Squamous NSCLC (NCT04925986) | Sarah Goldberg | 2022-02-10 |
| Confocal Laser Endomicroscopy Nodule Localization by Robotic Bronchoscopy (NCT05231278) | Johnson & Johnson Enterprise Innovation Inc. | 2022-01-20 |
| Effect of Muscle and Skin Fixation of Thoracic Drainage Tube on Postoperative Pain (NCT05202249) | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 2021-11-15 |
| Local Anesthesia Versus Combined Local Anesthesia With Single Dose Analgesia on Pain Control During Thoracic Ultrasound Guided Procedures (NCT05121233) | Assiut University | 2021-11-01 |
| Analysis of Factors and Treatment Related to Chronic Cough After Pulmonary Resection (NCT05586035) | Guangdong Provincial People's Hospital | 2021-09-02 |
| Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2) (NCT04283994) | University of Washington | 2021-07-26 |
| Comparison of Segmentectomy Versus Lobectomy for Non-small Cell Lung Cancer ≤ 2 cm in the Middle Third of the Lung Field (NCT04944563) | The First Affiliated Hospital with Nanjing Medical University | 2021-07-20 |
| (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC (NCT04862780) | Blueprint Medicines Corporation | 2021-06-29 |
| Lazertinib in Patients With NSCLC With Asymptomatic or Mild Symptomatic Brain Metastases After Failure of EGFR TKI. (NCT05326425) | Jin Hyoung Kang | 2021-06-23 |
| Practical Usability of EGFR Mutation Detection in ctDNA From Resectable NSCLC (NCT04922073) | Samsung Medical Center | 2021-06-01 |
| Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab (MK-3475) Monotherapy for Programmed Cell Death 1 Ligand 1 (PD-L1) Positive Metastatic Non-Small Cell Lung Cancer (MK-7684A-003, KEYVIBE-003) (NCT04738487) | Merck Sharp & Dohme LLC | 2021-04-07 |
| Korea Post Marketing Surveillance (PMS) Study of Vizimpro (NCT04721106) | Pfizer | 2021-03-07 |
| Intensified Chemo-immuno-radiotherapy With Durvalumab for Stage III Non-Small Cell Lung Cancers (NCT04230408) | Latin American Cooperative Oncology Group | 2021-03-05 |
| Safety and Effectiveness of Radiofrequency Ablation System in the Treatment of Peripheral Lung Tumors (NCT04619472) | Hangzhou Broncus Medical Co., Ltd. | 2021-01-07 |
| Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54 (NCT04577599) | Wake Forest University Health Sciences | 2021-01-07 |
| Impact on Quality of Life From Multi-modality Lung Cancer (NCT04540757) | The Christie NHS Foundation Trust | 2020-11-25 |
| Application of Three-Dimensionally Printed Navigational Template in Lung Biopsy (NCT04775901) | Shanghai Pulmonary Hospital, Shanghai, China | 2020-11-25 |
| Near-Infrared Perfusion During Minimally Invasive Thoracic Surgery Download (NCT05346380) | Massachusetts General Hospital | 2020-10-29 |
| Patient Skin Dose in Interventional Radiology (NCT04246125) | Assistance Publique - Hôpitaux de Paris | 2020-10-13 |
| Rehabilitation for Thoracoscopic Lobectomy (NCT04502654) | Rigshospitalet, Denmark | 2020-09-15 |
| Sintilimab After Stereotactic Ablation Brachytherapy for Refractory Oligometastatic Non-Small Cell Lung Cancer (NCT04486287) | Tianjin Medical University Second Hospital | 2020-09-01 |
| Evaluation of a Scalable Decision Support and Shared Decision Making Tool for Lung Cancer Screening (NCT04498052) | University of Utah | 2020-08-23 |
| ENB Vs. Conventional Bronchoscopy With Fluoroscopy for Safe and Effective Biopsy of Pulmonary Lesions (NCT04447482) | Shanghai Youhe Medical Technology Co., Ltd. | 2020-07-10 |
| Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012) (NCT04380636) | Merck Sharp & Dohme LLC | 2020-07-06 |
| Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients (NCT04566432) | Geneplus-Beijing Co. Ltd. | 2020-07-01 |
| Camrelizumab Combined With Apatinib Mesylate and Standard Chemotherapy (Pemetrixed + Carboplatin) in Patients With Tyrosine Kinase Inhibitor Failure in ALK-positive Advanced NSCLC (NCT04425135) | The First Affiliated Hospital of Xiamen University | 2020-07-01 |
| Local Therapy in Advanced NSCLC With Non-progressive Disease (PD) After First Line Therapy (NCT03046316) | Guangdong Association of Clinical Trials | 2020-06-01 |
| Lung Nodule Imaging Biobank for Radiomics and AI Research (NCT04270799) | Royal Marsden NHS Foundation Trust | 2020-06-01 |
| A Study of Smoking Cessation Patterns in Participants Undergoing Lung Surgery (NCT04313361) | Johnson & Johnson (China) Investment Ltd. | 2020-05-06 |
| Microwave Ablation of Primary and Secondary Lung Malignancies (NCT04369872) | University of Calgary | 2020-05-01 |
| Safety and Feasibility of Pulmonary Surgery Marker System in the Intraoperative Localization of Small Pulmonary Nodules (NCT04211051) | Ruijin Hospital | 2020-04-15 |
| ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting (NCT04241315) | On Target Laboratories, LLC | 2020-03-26 |
| Quantitative Diaphragmatic Ultrasound Evaluation in Pleural Effusions : A Feasability Study (NCT04264325) | University Hospital, Strasbourg, France | 2020-01-31 |
| A Prospective Cohort of Pulmonary Ground Glass Nodules Patients With Family History. (NCT04220268) | Guangdong Provincial People's Hospital | 2020-01-05 |
| Efficacy and Safety of Sintilimab With or Without Radiotherapy in Patients With Recurrent or IV NSCLC (EGFR -, ALK -) After Failure of Platinum-based Chemotherapy: A Randomized,Open Labled, Phase II Clinical Study (NCT04513301) | Shanghai Cancer Hospital, China | 2020-01-01 |
| Drug-Drug Interaction Study of TAK-788 and Midazolam in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) (NCT04051827) | Millennium Pharmaceuticals, Inc. | 2019-12-23 |
| Lung Cancer Rehabilitation After Medical Treatment (NCT04185467) | Nantong University | 2019-12-05 |
| Modified Versus Traditional Thoracic Drainage After Thoracoscopic Surgery (NCT04309955) | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 2019-12-01 |
| NGS-based Large-panel in Targeted Drug Delivery and Immunotherapy of Lung Cancer (NCT04159337) | Shanghai Chest Hospital | 2019-08-30 |
| Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases (NCT02859415) | National Cancer Institute (NCI) | 2019-08-08 |
| Promoting Smoking Cessation in Lung Cancer Screening Through Proactive Treatment (NCT03612804) | VA Office of Research and Development | 2019-05-10 |
| CIrculating Tumour DNA in Lung Cancer (CITaDeL): Optimizing Sensitivity and Clinical Utility (NCT03986463) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2019-05-01 |
| Anlotinib Therapy in Patients With Advanced Lung Cancer. (NCT03940404) | First People's Hospital of Hangzhou | 2019-05-01 |
| Detecting Lung Cancer Based on Exhaled Breath (NCT04419207) | Peking University People's Hospital | 2019-03-01 |
| Erector Spinae Plane Block Versus Paravertebral Block During Non-intubated Thoracoscopic Lung Resections. (NCT03137576) | IRCCS Sacro Cuore Don Calabria di Negrar | 2019-02-22 |
| Hybrid APC Therapy in Early Central Lung Neoplasms (NCT03537378) | Jiayuan Sun | 2018-12-26 |
| The Thoracic Peri-Operative Integrative Surgical Care Evaluation (POISE) Trial- Stage I (NCT02845479) | The Canadian College of Naturopathic Medicine | 2018-12-07 |
| McMaster Catheterization for Thoracoscopic Surgery Study (NCT02640326) | McMaster University | 2018-12-01 |
| Circulating Tumor DNA Detection in Surveillance of Surgical Lung Cancer Patients (NCT02696525) | Peking University People's Hospital | 2018-12-01 |
| A Study of SHR-1210 in Combination With BP102 in Subjects With Non-squamous NSCLC (NCT03666728) | Jiangsu HengRui Medicine Co., Ltd. | 2018-11-30 |
| The Effect of Pulmonary Rehabilitation on Pulmonary Function Tests, Exercise Capacity, and Quality of Life in Patients With Advanced-Stage Lung Cancer Receiving Chemotherapy (NCT07532057) | Istanbul Medipol University Hospital | 2018-11-01 |
| Computed Tomography Screening for Early Lung Cancer, COPD and Cardiovascular Disease in Shanghai, China (NCT03988322) | Shanghai Changzheng Hospital | 2018-09-01 |
| Efficacy and Safety Evaluation of Sintilimab in Patients With Advanced or Metastatic Non-squamous NSCLC (NCT03607539) | Innovent Biologics (Suzhou) Co. Ltd. | 2018-08-23 |
| China Lung Cancer Screening (CLUS) Study Version 2.0 (NCT03975504) | Shanghai Chest Hospital | 2018-08-01 |
| Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer (NCT03589950) | The First People's Hospital of Lianyungang | 2018-08-01 |
| Radiomics Multifactorial Biomarker for Pulmonary Nodules (NCT03872362) | Maastricht University | 2018-07-11 |
| Venous Thromboembolism in Advanced Lung Cancer (NCT03581708) | Guangdong Provincial People's Hospital | 2018-07-01 |
| Lung Nodule Prospective Database (NCT03922828) | Singapore General Hospital | 2018-05-01 |
| Comparison Between Wedge Resection and Segmentectomy for Ground Glass Opacity- Dominant Stage IA NSCLC (NCT02718365) | West China Hospital | 2017-12-07 |
| Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung Cancer (NCT02675088) | Chinese Academy of Medical Sciences | 2017-12-01 |
| Comparison of Post-operative Pain and Quality of Life Between Subxiphoid and Intercostal VATS for Lung Cancer (NCT03331588) | Shanghai Pulmonary Hospital, Shanghai, China | 2017-11-10 |
| Circulating Tumor Cells (CTC) in Lung Cancer (NCT02630615) | Shadia Jalal | 2017-10-19 |
| CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice (NCT02900248) | CureOne | 2017-10-02 |
| Pulmonary Ventilation/Perfusion Imaging for the Prediction of Postoperative Residual Pulmonary Function (NCT03357094) | Beijing Tongren Hospital | 2017-09-30 |
| Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers (NCT03212404) | Checkpoint Therapeutics, Inc. | 2017-09-20 |
| Audio Technology To Detect Lung Cancer Earlier (NCT03566862) | NHS Greater Glasgow and Clyde | 2017-05-16 |
| A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC (NCT03134872) | Jiangsu HengRui Medicine Co., Ltd. | 2017-05-12 |
| OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules (NCT02872701) | On Target Laboratories, LLC | 2017-05-04 |
| Molecular Profiling in Small Cell Lung Cancer (NCT03162705) | Zhujiang Hospital | 2017-05-03 |
| A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLC (NCT03085069) | Jiangsu HengRui Medicine Co., Ltd. | 2017-05-03 |
| Circulating Tumor DNA in Surgical Lung Cancer Patients (NCT03081741) | Shenzhen Gene Health Bio Tech Co., Ltd. | 2017-05-03 |
| Methods of Computed Tomography Screening and Management of Lung Cancer (NCT03992833) | Tianjin Medical University Cancer Institute and Hospital | 2017-05-01 |
| International Lung Screen Trial (ILST) (NCT02871856) | The University of Queensland | 2017-04-05 |
| The Watch the Spot Trial (NCT02623712) | Kaiser Permanente | 2017-03-06 |
| Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China (NCT03059641) | Geneplus-Beijing Co. Ltd. | 2017-02-22 |
| Detection of Heterogeneity in Central Lung Cancer - EBUS-TBNA and ctDNA Analysis vs. Endobronchial Forceps Biopsy (NCT03017183) | Wissenschaftliches Institut Bethanien e.V | 2017-01-02 |
| Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer (NCT02410603) | Mayo Clinic | 2016-12-01 |
| Development and Pilot Testing of a Clinical Informatics Lung Cancer Screening Intervention (NCT02962115) | Wake Forest University Health Sciences | 2016-11-01 |
| Dynamic Changes of Circulating Tumor DNA in Surgical Lung Cancer Patients (NCT02965391) | Peking University People's Hospital | 2016-11-01 |
| Sensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung Cancer (NCT02855281) | Wissenschaftliches Institut Bethanien e.V | 2016-10-01 |
| Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors (NCT02909452) | Syndax Pharmaceuticals | 2016-09-20 |
| Urinary Circulating Tumor DNA Detection in Non-small Cell Lung Cancer: a Prospective Study (NCT02907606) | Peking University People's Hospital | 2016-09-01 |
| Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors (NCT02926768) | Checkpoint Therapeutics, Inc. | 2016-09-01 |
| Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors (NCT02897778) | Syndax Pharmaceuticals | 2016-08-24 |
| Osimertinib in First and Second Line Treatment of NSCLC Harboring EGFR Mutations From Circulating Tumor DNA (NCT02769286) | Chonnam National University Hospital | 2016-08-01 |
| Management of Malignant Pleural Effusion - Indwelling Pleural Catheter or Talc Pleurodesis (NCT02825095) | Rambam Health Care Campus | 2016-08-01 |
| Virtual Intervention for Lung Cancer (NCT01684696) | University of California, San Francisco | 2016-08-01 |
| Anti-Mesothelin Antibody Drug Conjugate Anetumab Ravtansine for Mesothelin Expressing Lung Adenocarcinoma (NCT02839681) | National Cancer Institute (NCI) | 2016-07-19 |
| Patient Function/Fitness and Psychosocial Health in Improving Health-Related Quality of Life in Patients With Stage I-IV Non-Small Cell Lung Cancer (NCT02835066) | Wake Forest University Health Sciences | 2016-07-01 |
| MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s) (NCT02673021) | Mayo Clinic | 2016-06-08 |
| EBUS Score Validation for Malignancy (NCT02793713) | McMaster University | 2016-06-01 |
| Circulating Tumor DNA in Patients at High Risk for Lung Cancer (NCT02715102) | Pathway Genomics | 2016-06-01 |
| Afatinib in Lung Cancer With EGFR Mutation From Circulating Tumor DNA (NCT02629523) | Chonnam National University Hospital | 2016-06-01 |